Research progress on the role of pyroptosis in intestinal ischemia-reperfusion injury
- Author:
Yapeng LU
1
;
Yang LIU
1
;
Wei HAO
1
;
Hailian ZHONG
1
;
Jianqin XIE
1
;
Jieting LIU
1
;
Yingbin WANG
1
;
Yapeng LU
2
;
Yang LIU
2
;
Wei HAO
2
;
Hailian ZHONG
2
;
Jianqin XIE
2
;
Jieting LIU
2
;
Yingbin WANG
2
Author Information
- Publication Type:Journal Article
- Keywords: Inhibitor; Intestinal ischemia-reperfusion injury; Pyroptosis
- From: Chinese Journal of Clinical Pharmacology and Therapeutics 2021;26(12):1437-1443
- CountryChina
- Language:Chinese
- Abstract: Pyroptosis is a newly discovered programmed cell death that can lead to inflammatory response, its occurrence depends on the sequential activation of inflammatory bodies and caspase, and then the pore-forming generated by the fragmentation of gasdermin D and its cell membrane polymerization. Pyroptosis is mainly comprised of the pathway that depends on caspase-1 activated by flammasomes and the non-classical pathway that depends on caspase-4/5/11 activated by cytoplasmic lipopolysaccharide. As an important mechanism mediating the inflammatory response of the body, pyroptosis plays an irreplaceable role in the body's response to noxious stimuli, which is closely related to many diseases such as nervous system diseases, cardiovascular system diseases and tumors. Recent studies have found that pyroptosis also plays a key role in the occurrence of intestinal ischemia-reperfusion (II/RI). This paper reviews the molecular characteristics, mechanism of pyroptosis and its relationship with II/RI in recent years, in order to provide theoretical basis for the prevention and treatment of II/RI.
